Active Rheumatoid Arthritis clinical trials

Explore recruiting active rheumatoid arthritis clinical trials.

Recruiting active rheumatoid arthritis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Active Rheumatoid Arthritis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Multicenter, Platform Study of Targeted Therapies for the Treatment of Adult Subjects with Moderately to Severely Active Rheumatoid Arthritis.

Germany, Czechia, Hungary, Spain, Poland, Slovakia

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase IIa Double-Blind, Randomized, Parallel-Arm, Placebo-Controlled Trial To Investigate The Effects Of Three Dose Levels Of CIT-013 On Disease Activity In Patients With Moderately Active Rheumatoid Arthritis.

Netherlands, Poland, Belgium, Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

J1A-MC-KDAF: A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Peresolimab in Adult Participants with Moderately-to-Severely Active Rheumatoid Arthritis

Hungary, Spain, Italy, Poland, Greece

Therapeutic exploratory (Phase II) EU CTIS Study details

A MULTICENTER, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF SPIRONOLACTONE FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS (RA) - ALDORA

Germany, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

An international, multicentre, interventional, randomised assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active rheumatoid arthritis (MethMax trial)

Norway, Netherlands, Austria, Sweden, Romania, Italy

Therapeutic use (Phase IV) EU CTIS Study details

J3P-MC-FTAF: An Adaptive Phase 2a/2b, Randomized, Double-Blind, Placebo-Controlled Study of LY3871801 in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis

France, Czechia, Slovakia, Germany, Hungary, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Active Rheumatoid Arthritis trials by city

Active Rheumatoid Arthritis in Toronto Active Rheumatoid Arthritis in Vancouver Active Rheumatoid Arthritis in Montreal Active Rheumatoid Arthritis in Calgary Active Rheumatoid Arthritis in Edmonton Active Rheumatoid Arthritis in Ottawa Active Rheumatoid Arthritis in Winnipeg Active Rheumatoid Arthritis in Quebec City Active Rheumatoid Arthritis in Hamilton Active Rheumatoid Arthritis in Kitchener Active Rheumatoid Arthritis in London Active Rheumatoid Arthritis in Halifax Active Rheumatoid Arthritis in New York Active Rheumatoid Arthritis in Los Angeles Active Rheumatoid Arthritis in Chicago Active Rheumatoid Arthritis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease